Telomir Pharmaceuticals Secures $3M Investment to Advance Age-Reversal Research
Telomir Pharmaceuticals has received a strategic $3 million equity investment from The Bayshore Trust, bolstering its efforts to develop potential breakthrough therapies targeting age-related diseases and longevity.
